Breckenridge Pharmaceutical, Inc. recalls

17 recalls on record · latest: April 21, 2026

Official U.S. recall history for Breckenridge Pharmaceutical, Inc., compiled from official government records.

Get recall alerts

Free email alert whenever Breckenridge Pharmaceutical, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

April 21, 2026 · Drug & medication recalls Moderate risk CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recomm…

November 24, 2025 · Drug & medication recalls Moderate risk CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recomm…

November 24, 2025 · Drug & medication recalls Moderate risk CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recomm…

October 9, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limi…

August 8, 2025 · Drug & medication recalls Moderate risk CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.

July 25, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…

July 15, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessm…

June 30, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…

April 14, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above…

April 14, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above…

March 26, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI…

February 28, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…

February 28, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…

February 28, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommende…

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommende…

October 10, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommende…